Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy
- PMID: 29849203
- PMCID: PMC5949442
- DOI: 10.21037/jtd.2018.04.18
Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy
Conflict of interest statement
Conflicts of Interest: S Khanna serves as a consultant for Facile Therapeutics, Premier Inc., Probio Tech LLC, Rebiotix Inc. (paid to Mayo Clinic) and Shire Plc.
Comment in
-
The need to move away from fecal transplant towards targeted, refined microbiome therapy.J Thorac Dis. 2018 Oct;10(10):E755-E757. doi: 10.21037/jtd.2018.09.80. J Thorac Dis. 2018. PMID: 30505519 Free PMC article. No abstract available.
Comment on
-
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.JAMA. 2017 Nov 28;318(20):1985-1993. doi: 10.1001/jama.2017.17077. JAMA. 2017. PMID: 29183074 Free PMC article. Clinical Trial.
References
-
- McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:987-94. 10.1093/cid/ciy149 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources